Marinomed Biotech AG/ ATMARINOMED6 /
- - | Chg. - | Volume | Bid9:06:36 AM | Ask1:50:09 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
77.50EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 7.89 mill.EUR | - | - |
Assets
|
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | .2000 | .2000 | .2000 | 2.5000 | 6 | ||||||
Intangible Assets | 1.3000 | 1.3000 | 1.3000 | 1.6000 | 2.1000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | .0500 | .2000 | .1000 | .1000 | .9000 | ||||||
Accounts Receivable | - | - | - | - | - | ||||||
Cash and Cash Equivalents | 2 | 6 | 1.7000 | 12 | 9.2000 | ||||||
Current Assets | 3.4000 | 7.9000 | 3.7000 | 15.3000 | 15.4000 | ||||||
Total Assets | 4.9000 | 9.3000 | 5.3000 | 19.5000 | 23.5000 |
Liabilities
|
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | .3000 | .7000 | 2 | 1 | 2 | ||||||
Long-term debt | 4 | 7.5000 | 13.9000 | 4.6000 | 12.5000 | ||||||
Liabilities to Banks | 5.9000 | 12.2000 | 17.7000 | 4.7000 | 12.9000 | ||||||
Provisions | .8000 | .8000 | .8000 | 1.3000 | .8000 | ||||||
Liabilities | 7.6000 | 14.4000 | 21.5000 | 8.6000 | 18.1000 | ||||||
Share Capital | .1320 | .1320 | 1 | 1.4700 | 1.4730 | ||||||
Total Equity | -2.6000 | -5 | -16.3000 | 10.9000 | 5.4000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 4.9000 | 9.3000 | 5.3000 | 19.5000 | 23.5000 |
Income Statement
|
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.6000 | 4.8000 | 4.7000 | 6.1000 | 8.1000 | ||||||
Depreciation (total) | .2000 | .2000 | .2000 | .3000 | .4000 | ||||||
Operating Result | -1.5000 | -1.6000 | -5.1000 | -6.2000 | -5.8000 | ||||||
Interest Income | -.4000 | -.8000 | -7 | -1 | -.2000 | ||||||
Income Before Taxes | -2 | -2.4000 | -12.1000 | -7.2000 | -6 | ||||||
Income Taxes | .0020 | .0020 | 0.0000 | 0.0000 | 0.0000 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | -2 | -2.4000 | -12.1000 | -7.2000 | -6 |
Per Share
Cash Flow
|
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -2.5000 | -2.2000 | -4.3000 | -7.6000 | -6.9000 | ||||||
Cash Flow from Investing Activities | -.1000 | -.2000 | -.2000 | -2.4000 | -4 | ||||||
Cash Flow from Financing | 1 | 6.4000 | .2000 | 20.3000 | 8 | ||||||
Decrease / Increase in Cash | -1.6000 | 4 | -4.3000 | 10.3000 | -2.8000 | ||||||
Employees | - | 27 | 32 | 35 | 42 |